NET PROFIT (x1000 NOK)
EMPLOYEES
Biomedrex AB
Closing information (x1000 NOK)
| Closing information | 2025/06 | 2024/06 | 2023/06 |
| Turnover |
0
|
0
|
0 |
| Financial expenses |
1,926
|
126
|
200 |
| Earnings before taxes |
-583
|
319
|
380 |
| EBITDA |
1,322
|
443
|
575 |
| Total assets |
20,004
|
17,237
|
15,817 |
| Current assets |
172
|
46
|
197 |
| Current liabilities |
4,572
|
3,875
|
3,731 |
| Equity capital |
6,871
|
5,036
|
4,657 |
| - share capital |
53
|
50
|
50 |
| Employees (average) |
3
|
3
|
3 |
Financial ratios
| Fiscal year | 2025/06 | 2024/06 | 2023/06 |
| Solvency |
34.3%
|
29.2%
|
29.4% |
| Turnover per employee |
0
|
0
|
0 |
| Profit as a percentage of turnover | |||
| Return on assets (ROA) |
6.7%
|
2.6%
|
3.7% |
| Current ratio |
3.8%
|
1.2%
|
5.3% |
| Return on equity (ROE) |
-8.5%
|
6.3%
|
8.2% |
| Change turnover |
0
|
0
|
0 |
| Change turnover % | |||
| Chg. No. of employees |
0
|
0
|
-5 |
| Chg. No. of employees % |
0%
|
0%
|
-63% |
Total value of public sale
| Fiscal year | 2025/06 | 2024/06 | 2023/06 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.